Tower Research Capital LLC TRC Increases Position in Relx Plc (NYSE:RELX)

Tower Research Capital LLC TRC raised its holdings in shares of Relx Plc (NYSE:RELX) by 361.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 50,986 shares of the technology company’s stock after purchasing an additional 39,935 shares during the period. Tower Research Capital LLC TRC’s holdings in Relx were worth $2,316,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new stake in Relx during the 4th quarter valued at about $44,516,000. Bank of Montreal Can grew its holdings in shares of Relx by 290.3% during the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company’s stock valued at $40,277,000 after buying an additional 659,547 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Relx by 50.3% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock valued at $89,420,000 after acquiring an additional 658,655 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Relx in the 4th quarter worth approximately $9,920,000. Finally, ABC Arbitrage SA bought a new position in Relx in the 4th quarter valued at approximately $6,296,000. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on RELX. The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, March 26th. They issued a “buy” rating for the company. Redburn Atlantic began coverage on shares of Relx in a research note on Wednesday, January 8th. They set a “buy” rating on the stock. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. StockNews.com downgraded shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Finally, Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Relx presently has an average rating of “Buy”.

Relx Trading Up 2.0 %

Relx stock opened at $53.10 on Wednesday. Relx Plc has a 52-week low of $40.25 and a 52-week high of $53.15. The company has a market cap of $98.28 billion, a P/E ratio of 28.55, a P/E/G ratio of 2.73 and a beta of 0.84. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The business has a 50-day simple moving average of $49.41 and a two-hundred day simple moving average of $48.09.

Relx Increases Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a dividend of $0.5586 per share. This represents a yield of 1.6%. This is a positive change from Relx’s previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. Relx’s payout ratio is 59.68%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.